Amarin Corp. Plc
(NASDAQ : AMRN)

( )
AMRN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc 5.32%76.066.2%$205.22m
VRXValeant Pharmaceuticals International, Inc. -10.38%18.0414.1%$106.15m
CTLTCatalent, Inc. -0.03%88.162.2%$89.17m
JAZZJazz Pharmaceuticals Plc -0.78%126.082.4%$76.67m
BHCBausch Health Cos., Inc. -10.38%18.040.0%$75.32m
TNXPTonix Pharmaceuticals Holding Corp. -3.33%1.160.5%$57.52m
PRGOPerrigo Co. Plc -0.02%50.456.8%$45.46m
ARGXargenx SE -0.15%230.760.0%$42.63m
GWPHGW Pharmaceuticals Plc -17.21%109.376.2%$42.38m
ICLRICON plc 0.30%189.914.3%$41.81m
PCRXPacira Biosciences, Inc. 0.38%58.3510.3%$39.85m
AMRNAmarin Corp. Plc -0.71%7.001.5%$39.83m
MYOKMyoKardia, Inc. 3.12%103.401.8%$38.76m
ICPTIntercept Pharmaceuticals, Inc. 3.33%48.7516.8%$38.58m
UTHRUnited Therapeutics Corp. 0.53%112.7914.1%$37.15m

Company Profile

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.